Our team is always thinking about how to conquer and foresee the most significant industry issues facing our clients. Over the the next year, we will touch on cutting edge topics such as digital health, clinical trials, supply chain, Brexit, and more.
In our first episode, Elisabethann Wright and Robert F. Church from our Global Regulatory practice explore questions around the use of digital tools in clinical trials and how they are regulated by international authorities. They highlight the confusion around clinical trials within the European GDPR framework.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
